Vega BioImaging ^Company

VEGA BioImaging increases the accuracy of cancer diagnostics to ensure all patients receive the most appropriate treatment, improve their chances of survival, and enhance their quality of life during treatment. VEGA offers a novel immunolabeling technology that uses nanobeads of different colors to target specific proteins, adding quantitative and precise results to biopsy analysis for predicting the effectiveness of oncology drugs. This solution will enable better stratification of cancer patients and better determination of their eligibility for precision treatments. The VEGA solution consists of three components: a protein detection kit, a slide digitizing system that easily integrates with existing microscopy systems, and quantification software based on artificial intelligence.